ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,000 | +33.3% | 247 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -62.5% | 247 | -61.3% | 0.00% | – |
| Q4 2017 | $8,000 | -27.3% | 638 | -26.6% | 0.00% | – |
| Q3 2017 | $11,000 | +57.1% | 869 | +39.0% | 0.00% | – |
| Q2 2017 | $7,000 | -46.2% | 625 | -1.1% | 0.00% | – |
| Q1 2017 | $13,000 | +85.7% | 632 | +81.6% | 0.00% | – |
| Q4 2016 | $7,000 | -75.9% | 348 | -70.4% | 0.00% | – |
| Q2 2016 | $29,000 | -9.4% | 1,175 | -9.7% | 0.00% | – |
| Q1 2016 | $32,000 | -34.7% | 1,301 | -11.5% | 0.00% | – |
| Q4 2015 | $49,000 | +2.1% | 1,470 | -0.4% | 0.00% | – |
| Q3 2015 | $48,000 | – | 1,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |